GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Market Cap
TRY49.66bn
Enterprise Value
TRY50.65bn
Revenue
TRY19.18bn

Annual cashflow statement for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	310	640	656	195	814
Depreciation
Deferred Taxes
Non-Cash Items	-62.5	393	419	472	578
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-133	-703	-1,162	1,014	-1,109
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	159	379	6.51	2,485	1,365
Capital Expenditures	-172	-334	-1,023	-774	-984
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-100	-658	87.7	1,123	-1,772
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-272	-992	-936	349	-2,756
Financing Cash Flow Items	19.6	-32.3	-327	-882	-859
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	507	-148	95.8	-2,250	775
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	461	-761	-833	583	-617